GlassScriptPhysician profile
Stephen M Kubaska
NPI 1952481160
$8,963.82
in general payments reported to CMS, 2019-2025
33 companies · $2,296 in 2025
The $2,296 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,070 · 2020: $416 · 2021: $972 · 2022: $1,063 · 2023: $486 · 2024: $1,661 · 2025: $2,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,422 · Consulting Fee: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,422.17 |
| Consulting Fee | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,467.45 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis, Gore Excluder Iliac Branch Endoprosthesis |
| Medtronic, INC. | $1,322.78 | 2021-2025 | Endurant Iis, Valiant Captivia, Venaseal |
| Silk Road Medical, INC. | $1,086.47 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $1,030.30 | 2019-2025 | Zilver Ptx, Rosen, Zenith |
| Janssen Pharmaceuticals, INC | $298.34 | 2019-2022 | |
| Penumbra, INC. | $296.43 | 2019-2024 | Indigo System |
| Shockwave Medical, INC | $288.96 | 2025 | |
| Pfizer INC. | $257.71 | 2020-2022 | |
| Abbott Laboratories | $221.17 | 2019 | |
| Boston Scientific Corporation | $167.33 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Sirtex Medical INC | $137.40 | 2025 | Sir-Spheres Microspheres |
| Integra Lifesciences Corporation | $133.20 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cvrx, INC. | $129.19 | 2022 | |
| Smith+Nephew, INC. | $128.28 | 2019-2020 | |
| Inari Medical, INC. | $123.65 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $116.75 | 2024-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Ziehm-Orthoscan, INC. | $114.28 | 2019 | |
| Lemaitre Vascular, INC. | $91.93 | 2019-2025 | Artegraft Vascular Graft |
| Urgo Medical North America, LLC | $76.15 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Urgoclean Ag |
| Inspiremd LTD | $73.43 | 2025 | Cguard Prime Carotid Stent System |
| Baxter Healthcare | $57.58 | 2024 | Preveleak |
| Philips North America LLC | $50.33 | 2025 | Fors Components |
| Stryker Corporation | $48.09 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tactile Systems Technology INC | $44.33 | 2019-2021 | |
| Merit Medical Systems INC | $38.12 | 2025 | Wrapsody Stent Graft |
| Acell, INC. | $29.87 | 2019 | |
| Veryan Medical Incorporated | $22.84 | 2021 | |
| My01 INC. | $21.96 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Terumo Medical Corporation | $20.02 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $19.15 | 2019 | |
| Solventum Corporation | $17.73 | 2024 | Prevena, V.A.C.Instill |
| Janssen Scientific Affairs, LLC | $17.70 | 2021 | |
| Advanced Oxygen Therapy INC. | $14.90 | 2024 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kubaska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.